+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nanobiotix  - logo

Nanobiotix is a nanomedicine company dedicated to the development of new treatments for cancer based on the combined application of nanotechnologies and biotechnologies. Nanobiotix has developed a new class of therapeutics based on nanoparticles, NanoXray™ therapeutics. They consist of inert nanoparticles designed to enter tumor cells. Upon activation by a standard dose of radiation, they release a tremendous amount of energy that destroys cancer cells, whilst the surrounding healthy tissues are preserved and receive the same dose of radiation as in standard radiotherapy. Founded in 2003, the company is based in Paris.

From
From
From
From
From
From
From
From
Soft Tissue Sarcoma - Pipeline Insight, 2021 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 248 Pages
From
From
Nanopharmaceuticals - Thematic Research - Product Thumbnail Image

Nanopharmaceuticals - Thematic Research

  • Report
  • March 2020
  • 96 Pages
From
Nanobiotix SA (NANO) - Product Pipeline Analysis, 2021 Update - Product Thumbnail Image

Nanobiotix SA (NANO) - Product Pipeline Analysis, 2021 Update

  • Company Profile
  • December 2021
  • 49 Pages
From
  • 17 Results (Page 1 of 1)
Loading Indicator